In focus · trending topic

Exosome Diagnostics

3 stories · following the connections

CareFirst BlueCross BlueShield Announces Coverage of New Liquid Biopsy Tests for Prostate Cancer

By Nasdaq OMXJan 8, 2018, 2:58 PM UTC

CareFirst BlueCross BlueShield and Exosome Diagnostics Announce Evidence Development Collaboration for Molecular Diagnostic Tests

By Nasdaq OMXAug 24, 2017, 1:12 PM UTC

American Medical Association (AMA) Grants Exosome Diagnostics a CPT PLA Specific to Its ExoDx® Prostate(IntelliScore) Test

By Nasdaq OMXApr 26, 2017, 12:22 PM UTC